Intellia Therapeutics(NTLA) - 2022 Q4 - Earnings Call Transcript
Intellia Therapeutics(NTLA)2023-02-24 02:05
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2022 Results Conference Call February 23, 2023 8:00 AM ET Company Participants Ian Karp - Senior Vice President, Investor Relations and Corporate Communications John Leonard - Chief Executive Officer David Lebwohl - Chief Medical Officer Laura Sepp-Lorenzino - Chief Scientific Officer Glenn Goddard - Chief Financial Officer Conference Call Participants Maury Raycroft - Jeffries Greg Harrison - Bank of America Swapnil Malekar - Piper Sandler Terence Flynn - Morgan ...